AD4-22960-10131
3 vaccinations
5 coded responses
40 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 490 / MI
- Registered
- 2021-02-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-02
Registered in v-safe
-
2021-02-02
Dose 1 — Moderna
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
-
2021-03-02
Dose 2 — Moderna
- 2021-03-02
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · Headache, NauseaAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · Headache, Fatigue or tirednessAdult check-in
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-06-01
-
2021-08-26
Dose 3 — Moderna
- 2021-08-26
-
2021-08-27
Survey response — days 1–6 daily, dose 3MedDRA: Body temperature decreased — Feeling: Fair · Site: Pain, Redness · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painFree text: Temp is elevated to 98.3 but my baseline is 96.8MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-28
- 2021-08-29
- 2021-08-30
- 2021-08-31
- 2021-09-01
- 2021-09-02
- 2021-09-09
-
2021-09-16
Survey response — day 21, dose 3MedDRA: Crohn's disease, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Flare-up of Crohns diseaseMedDRA releases: 2024-11 · check-in free text available
-
2021-09-16
Report sent to call center — day 21, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-20
-
2021-09-23
Survey response — day 28, dose 3MedDRA: Crohn's disease, Pre-existing disease — Feeling: GoodFree text: Flare up of CrohnsMedDRA releases: 2024-11 · check-in free text available
- 2021-09-30
- 2021-10-07
- 2021-11-25
-
2022-02-24
Survey response — 6 months, dose 3MedDRA: Fatigue, Headache, Impaired work ability, Respiratory tract congestion, Rhinitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Prolonged fatigue (8 weeks & continuing) and other relatively mild s/s (headache, mild congestion, rhinitis) secondary to COVID. Was unable to work for approximately one week, then returned to work and normal activities as able to tolerate.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-26
Survey response — 12 months, dose 3MedDRA: Asthenia, Brain fog, Colitis, Fatigue, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Excessive fatigue and loss of endurance, brain fog, increased GI issues ( I have chronic colitis).MedDRA releases: 2024-11 · check-in free text available
-
2022-08-26
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-08-29
Call successfulNot applicable - Accidental Reporting
-
2022-08-29
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-02 | Moderna | |
| 2 | 2021-03-02 | Moderna | |
| 3 | 2021-08-26 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Temp is elevated to 98.3 but my baseline is 96.8
Release 9 — day 21, dose 3
Symptoms: Flare-up of Crohns disease
Release 9 — day 28, dose 3
Symptoms: Flare up of Crohns
Release 11 — 6 months, dose 3
Symptoms: Prolonged fatigue (8 weeks & continuing) and other relatively mild s/s (headache, mild congestion, rhinitis) secondary to COVID. Was unable to work for approximately one week, then returned to work and normal activities as able to tolerate.
Release 12 — 12 months, dose 3
Symptoms: Excessive fatigue and loss of endurance, brain fog, increased GI issues ( I have chronic colitis).
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Colitis | · | · | ✓ |
| SD | Crohn's disease | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinitis | · | · | ✓ |
| SRO | Body temperature decreased | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release